Search Results - "Barker, Shannon D"
-
1
Targeting Adenovirus to the Serotype 3 Receptor Increases Gene Transfer Efficiency to Ovarian Cancer Cells
Published in Clinical cancer research (01-01-2002)“…Gene delivery efficiency in clinical cancer gene therapy trials with recombinant adenoviruses (Ads) based on serotype 5 (Ad5) has been limited partly because…”
Get full text
Journal Article -
2
Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer
Published in Journal of gastroenterology (01-01-2005)“…Gastric cancer is the fourth most common malignancy worldwide. Adenoviral vectors (Ads) have been applied for gene therapy of various cancers because of their…”
Get full text
Journal Article -
3
CD40 Is Expressed on Ovarian Cancer Cells and Can Be Utilized for Targeting Adenoviruses
Published in Clinical cancer research (01-02-2003)“…Purpose: CD40, a member of the tumor necrosis factor receptor superfamily, is widely expressed on various cell types in addition to hematopoietic cells. Recent…”
Get full text
Journal Article -
4
The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy
Published in The journal of gene medicine (01-04-2003)“…Background Adenoviruses allow efficient transduction of dividing and non‐dividing cells and their safety for the treatment of cancer has been established in…”
Get full text
Journal Article -
5
Strategies to Accomplish Targeted Expression of Transgenes in Ovarian Cancer for Molecular Therapeutic Applications
Published in Clinical cancer research (01-08-2001)“…Purpose: The purpose of the study was to determine the capability of the midkine (MK) and cycooxygenase -2 (cox-2) gene promoter regions to function as…”
Get full text
Journal Article -
6
Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review)
Published in International journal of oncology (01-12-2002)“…Gene therapy is an exciting novel approach for treating cancers resistant to currently available modalities. Treatment approaches are based on taking advantage…”
Get more information
Journal Article -
7
Development of a Genomic DNA Reference Material Panel for Rett Syndrome ( MECP2 -Related Disorders) Genetic Testing
Published in The Journal of molecular diagnostics : JMD (01-03-2014)“…Rett syndrome is a dominant X-linked disorder caused by point mutations (approximately 80%) or by deletions or insertions (approximately 15% to 18%) in the…”
Get full text
Journal Article -
8
Development of Genomic Reference Materials for Cystic Fibrosis Genetic Testing
Published in The Journal of molecular diagnostics : JMD (01-05-2009)“…The number of different laboratories that perform genetic testing for cystic fibrosis is increasing. However, there are a limited number of quality control and…”
Get full text
Journal Article -
9
Development and Characterization of Reference Materials for MTHFR , SERPINA1 , RET , BRCA1 , and BRCA2 Genetic Testing
Published in The Journal of molecular diagnostics : JMD (01-11-2009)“…Well-characterized reference materials (RMs) are integral in maintaining clinical laboratory quality assurance for genetic testing. These RMs can be used for…”
Get full text
Journal Article -
10
Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids
Published in Cancer gene therapy (01-05-2003)“…Replication competent viruses hold promise for treatment of advanced cancers resistant to available therapeutic modalities. Although preliminary clinical…”
Get full text
Journal Article